Skip to main content

Abstract Submission Guidelines

  1. Overview
    All abstracts must align with one of the designated scientific categories and demonstrate relevance to clinical practice, research, or innovation in ophthalmology.

    Abstract Submission Guidelines

  2. Scientific Categories

    Authors must select one primary category from the following:

    • Cataract
    • Cornea and Ocular Surface
    • General Ophthalmology
    • Glaucoma
    • Myopia
    • Oculofacial Surgery
    • Ophthalmic Oncology
    • Paediatric Ophthalmology and Strabismus
    • Medical and Surgical Retina
    • Thyroid Eye Disease (TED)
    • Uveitis and Ocular Immunology

    The Scientific Committee reserves the right to reassign abstracts to another category where appropriate.

  3. Author and Submitter Roles

    Each abstract may include a maximum of one first author and five co-authors. Each individual may be listed on a maximum of two submissions across all submission formats.

    The submitter may be any author or authorised representative and will receive all correspondence; a valid email address is therefore required.

    Abstracts submitted should represent original work. Previously presented material may be considered if clearly disclosed at the time of submission. Abstracts that have been formally published in peer-reviewed journals prior to submission are generally not eligible for consideration.

    The first author of each accepted submission must register for the Congress by the stipulated registration deadline. Failure to do so may result in withdrawal of the submission from the Congress.

    Requests for withdrawal of submissions must be submitted in writing to the Congress Secretariat prior to the final submission deadline. Failure to provide prior notice of withdrawal may affect consideration of future submissions.

    By submitting, accepted authors consent to the display, publication, and inclusion of their work in Congress materials, publications, digital platforms, the Congress website, mobile application, and e-booklet, including publication prior to the meeting where applicable.

  4. Submission Formats

    The Congress accepts submissions under the following formats:

    • E-Poster Submissions
    • Clinical Video Submissions
    • Surgical Video Submissions

    Please refer to the submission overview above for the scope and suitability of each format.

    General Academic Requirements

    All submissions must:

    • Be conducted using sound methodology with sufficient data to support conclusions.
    • Disclose financial interests via the submission platform.
    • Exclude author names, institutional identifiers, and affiliated institutions from the abstract title and body to facilitate blinded review.
    • Declare author affiliations separately during submission.

  5. Abstract Requirements

    E-Poster Abstract Submission

    E-Poster abstracts must follow this structure:

    Title; Purpose; Methods; Results; and Conclusion

    Author names and affiliations should be entered separately within the submission platform and must not appear in the abstract body.

    Clinical and Surgical Video Abstract Submission

    Authors submitting a clinical or surgical video must also provide a brief written description to assist the Scientific Committee in reviewing the submission.

    The description should summarise:

    • The objective of the video
    • The technique or approach demonstrated
    • The key educational or clinical learning points

    Submissions must follow this structure:

    Title and Description

    Author names and affiliations should be entered separately within the submission platform and must not appear in the abstract body.

  6. Submission Criteria

    • All abstracts must be written in clear UK English, free of patient identifiers, and compliant with applicable confidentiality requirements.
    • Generic drug and device names must be used throughout to avoid commercial bias.
    • Studies involving human participants must comply with applicable institutional and national ethical standards. Appropriate ethics approval and informed consent must be obtained where required.
    • For case reports or submissions containing identifiable clinical information or images, authors are responsible for obtaining written patient consent where required.
    • Conflicts of interest and sources of funding must be disclosed.
    • All co-authors must approve the abstract prior to submission.
    • The use of generative artificial intelligence tools for language refinement is permitted, provided that authors retain full responsibility for the scientific accuracy, originality, and integrity of the submission.
    • Fabricated data, manipulated images, or AI-generated scientific content without appropriate human oversight are strictly prohibited.
    • To facilitate blinded review, the title and abstract body must not contain author names, institutional identifiers, or other information that may reveal the identity of the authors or institutions.
    • Titles must follow AMA capitalisation style. Abbreviations are not permitted in titles.
    • Abbreviations used in the body text must be defined at first use.
    • Graphs, tables, images, and references must not be included in the abstract body.
    • Authors are responsible for the accuracy of spelling and grammar, although the Abstract Reviewing Committee reserves the right to correct minor language, formatting, or title-related errors where necessary.
    • Authors whose first language is not English are encouraged to seek appropriate proofreading support prior to submission.
    • All submission deadlines refer to Singapore Time (SGT, UTC+8).
    • No revisions to submitted abstracts will be permitted after the submission deadline unless requested by the Scientific Committee.

  7. Review and Selection Process

    All submissions will undergo peer review by the Scientific Committee.

    Accepted submissions will be featured as e-posters or video showcases, and the Scientific Committee reserves the right to reassign submission formats where necessary.

    Abstracts will be assessed based on the following criteria:

    • Relevance to ophthalmology and the selected category
    • Clarity and significance of the clinical or research question
    • Methodological rigour or technical quality
    • Originality and innovation
    • Clinical impact and translational value
    • Educational value, particularly for video submissions

    These criteria align with international scientific conference standards.

    The Scientific Committee and Organising Committee reserve the right to reject, withdraw, or remove any submission that does not comply with the submission guidelines, ethical standards, or Congress policies. The decision of the Scientific Committee is final.

  8. Technical Specifications for Video Submissions

    Videos must:

    • Not exceed 5 minutes in duration.
    • Be submitted in MP4 format with H.264 encoding.
    • Have a minimum resolution of 1080p.
    • Be below 500MB in file size.
    • Include narration or subtitles.
    • Include labels or annotations where appropriate.
    • Include documented patient consent for any identifiable content.

  9. Key Dates

    MilestoneDate
    Abstract Submission Deadline 9 August 2026
    Notification of Acceptance 17 August 2026

    Notifications will be sent to the corresponding author via email.

  10. Permissions and Compliance

    All necessary permissions must be obtained for the use of visual and audio materials, including licensing for any copyrighted content and informed consent from identifiable patients or individuals.

  11. Copyright

    The National University Hospital (S) Pte Ltd holds copyright to all materials displayed at the Congress and may reproduce them for educational and distribution purposes.

  12. Enquiries

    For enquiries regarding abstract submission, please contact the Congress Secretariat at: This email address is being protected from spambots. You need JavaScript enabled to view it.

Please read and accept before proceeding.

Section A: Presenter and Contact Details

Corresponding/Submitting Author (Primary Contact)

 

Please select one
Please enter full name
Please enter email
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co author/s

Co-Author 1

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 2

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 3

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 4

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 5

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 6

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 7

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 8

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 9

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 10

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 11

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 12

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 13

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 14

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 15

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 16

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 17

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 18

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 19

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select
Invalid Input

Co-Author 20

Please select one
Please enter full name
Please enter organisation
please enter affiliations
Please select

Section B: Presentation and Themes

All abstracts must align with one of the designated scientific categories and demonstrate relevance to clinical practice, research, or innovation in ophthalmology.

Please select
Please select

Note: The Scientific Committee reserves the right to reassign where appropriate.

Section C
E-Poster Content (Free Text)
Please enter title of abstract
Follow AMA title capitalisation style. Do not include abbreviations, individual names, or institution names in the title.
Type of submission
Type of submission


Please select one

Structured abstract text (max 300 words)

Maximum 300 words in clear UK English. Do not include individual or institution names. When abbreviations are used in the body text, each abbreviation should be defined the first time it appears by placing its full form in parentheses.

Invalid Input
Invalid Input
Invalid Input
Invalid Input
Authors submitting a video must also provide a brief written description to assist the Scientific Committee in reviewing the submission. The description should cover, in prose, the objective of the video, the technique or approach demonstrated, and the key learning points. It must follow this structure: Title; Authors and Affiliations; and Description.
Please enter title of video
Invalid Input

Technical specifications:

  • Technical specifications:
  • Duration: Maximum 5 minutes
  • Format: MP4, H.264 encoded
  • File size: Less than 500MB
  • Resolution: 1080p recommended

Must include:

  • Narration or subtitles
  • Labels/annotations where appropriate
  • Patient consent for identifiable content
Invalid Input
Section D: Ethics and Compliance
Has ethics approval been obtained for this study?
Has ethics approval been obtained for this study?

Please select
Please provide approval reference
Does the submission contain identifiable patient information or footage?
Does the submission contain identifiable patient information or footage?
Please select
Have all necessary licences and permissions been obtained for copyrighted content used in the video?
Have all necessary licences and permissions been obtained for copyrighted content used in the video?
Please select
Section E: Conflict of Interest Disclosure
Do any authors have financial interests relevant to this submission?
Do any authors have financial interests relevant to this submission?
Invalid Input
Invalid Input
Consent and Permissions
By submitting this abstract, I confirm that
By submitting this abstract, I confirm that





Please confirm

For enquiries, please contact the Congress Secretariat at This email address is being protected from spambots. You need JavaScript enabled to view it.

Abstract Submission Deadline: 30 June 2026